Jaguar Health Inc (JAGX)
0.1604
-0.01
(-5.59%)
USD |
NASDAQ |
Apr 25, 10:02
Jaguar Health Cash from Financing (TTM): 34.23M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 34.23M |
September 30, 2023 | 25.22M |
June 30, 2023 | 33.95M |
March 31, 2023 | 33.84M |
December 31, 2022 | 23.18M |
September 30, 2022 | 24.66M |
June 30, 2022 | 14.89M |
March 31, 2022 | 21.22M |
December 31, 2021 | 43.94M |
September 30, 2021 | 51.62M |
June 30, 2021 | 52.50M |
March 31, 2021 | 48.34M |
December 31, 2020 | 19.49M |
September 30, 2020 | 13.64M |
June 30, 2020 | 21.39M |
March 31, 2020 | 20.33M |
December 31, 2019 | 21.77M |
September 30, 2019 | 23.56M |
June 30, 2019 | 15.68M |
Date | Value |
---|---|
March 31, 2019 | 11.34M |
December 31, 2018 | 24.55M |
September 30, 2018 | 23.17M |
June 30, 2018 | 24.59M |
March 31, 2018 | 27.30M |
December 31, 2017 | 10.68M |
September 30, 2017 | 6.698M |
June 30, 2017 | 5.324M |
March 31, 2017 | 1.384M |
December 31, 2016 | 5.283M |
September 30, 2016 | 3.645M |
June 30, 2016 | 8.330M |
March 31, 2016 | 26.88M |
December 31, 2015 | 24.17M |
September 30, 2015 | 25.34M |
June 30, 2015 | 18.71M |
March 31, 2015 | 2.638M |
December 31, 2014 | 6.074M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
13.64M
Minimum
Sep 2020
52.50M
Maximum
Jun 2021
28.60M
Average
23.56M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
BioSig Technologies Inc | 17.33M |
BioVie Inc | 15.36M |
First Wave BioPharma Inc | 15.23M |
Genprex Inc | 10.59M |
Adial Pharmaceuticals Inc | 4.132M |